Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer.

Gong ChenJunjie PengQian XiaoHao-Xiang WuXiaojun WuFulong WangLiren LiPeirong DingQi ZhaoYaqi LiDa WangYang ShaoHua BaoZhizhong PanKe-Feng DingSanjun CaiFeng WangRui-Hua Xu

Published in: Journal of hematology & oncology (2021)

Postoperative serial ctDNA detection predicted high relapse risk and identified disease recurrence ahead of radiological imaging in patients with stage II/III CRC. ctDNA may be used to guide the decision-making in postsurgical management.

Keyphrases

circulating tumor
cell free
circulating tumor cells
free survival
patients undergoing
high resolution
quantum dots